A patient with suppressed thyroid‑stimulating hormone (TSH 0.10 µIU/mL), elevated free thyroxine (free T4 2.72 ng/dL) and high‑normal total triiodothyronine (total T3 5.3 pg/mL) – does this indicate overt hyperthyroidism and what is the appropriate initial management?

Overt Hyperthyroidism Confirmed – Immediate Antithyroid Treatment Required

This patient has overt hyperthyroidism requiring prompt pharmacologic intervention with antithyroid drugs, as the combination of suppressed TSH (0.10 µIU/mL), elevated free T4 (2.72 ng/dL), and high-normal T3 (5.3 pg/mL) definitively establishes thyroid hormone excess. 1, 2, 3

---

Diagnostic Confirmation

Laboratory Pattern Analysis

• TSH 0.10 µIU/mL (suppressed) – indicates autonomous thyroid hormone production with complete suppression of pituitary thyrotroph function 1, 3
• Free T4 2.72 ng/dL (elevated) – confirms excessive circulating thyroid hormone and distinguishes overt from subclinical hyperthyroidism 1, 2
• Total T3 5.3 pg/mL (high-normal) – rules out isolated T3 toxicosis but confirms thyroid hormone excess 3, 4

This triad of suppressed TSH with elevated free T4 is the hallmark of overt hyperthyroidism and mandates treatment regardless of symptom severity 1, 2, 3.

Distinguishing from Subclinical Disease

• Subclinical hyperthyroidism presents with low TSH but normal free T4 and T3 5
• This patient's elevated free T4 definitively establishes overt disease requiring immediate intervention 1, 2

---

Immediate Management Algorithm

Step 1: Confirm Etiology Before Treatment Selection

Measure TSH-receptor antibodies (TRAB) and obtain thyroid ultrasound to distinguish Graves' disease from toxic nodular goiter, as this determines definitive therapy 5, 2:

• TRAB positive → Graves' disease → antithyroid drugs ± radioactive iodine
• TRAB negative + nodular ultrasound → toxic adenoma/multinodular goiter → radioactive iodine or surgery 5, 2

Step 2: Initiate Antithyroid Drug Therapy Immediately

Start propylthiouracil (PTU) 300 mg daily in three divided doses (100 mg every 8 hours) as initial therapy for overt hyperthyroidism 6:

• For severe hyperthyroidism or very large goiters, increase to 400 mg daily 6
• Maintenance dose typically 100–150 mg daily once euthyroid 6
• Alternative: Methimazole 15–30 mg daily (single dose) may be preferred in non-pregnant adults due to once-daily dosing and lower hepatotoxicity risk

Step 3: Symptomatic Management

Add beta-blocker therapy for immediate symptom control while awaiting antithyroid drug effect 5:

• Propranolol 20–40 mg three times daily, or
• Atenolol 25–50 mg once daily
• Provides rapid relief of palpitations, tremor, heat intolerance, and anxiety 5

Step 4: Monitoring Protocol

Recheck free T4 and free T3 in 4–6 weeks after initiating antithyroid drugs 7:

• TSH remains suppressed for weeks to months despite normalization of thyroid hormones 5, 7
• Do not use TSH alone to guide dose adjustments in the first 3–6 months 7
• Once free T4 normalizes, check TSH, free T4, and free T3 every 6–8 weeks during titration 7

---

Critical Safety Considerations

Cardiovascular Risk Mitigation

• Elderly patients or those with cardiac disease are at high risk for atrial fibrillation, heart failure, and myocardial ischemia from untreated hyperthyroidism 5
• Obtain baseline ECG to screen for atrial fibrillation 5
• More aggressive beta-blockade may be required in patients >65 years 5

Bone Health Protection

• Overt hyperthyroidism accelerates bone loss and increases fracture risk, particularly in postmenopausal women 5
• Ensure adequate calcium (1200 mg/day) and vitamin D (1000 units/day) intake during treatment 8

Iodine Exposure Precaution

• Avoid iodinated contrast agents (CT scans, angiography) until euthyroid, as iodine load can precipitate thyroid storm in patients with nodular disease 5
• If contrast study is unavoidable, pretreat with antithyroid drugs and beta-blockers 5

---

Common Pitfalls to Avoid

Do Not Delay Treatment Pending Etiology Determination

• Antithyroid drugs should be started immediately based on biochemical hyperthyroidism 6, 2
• Etiology workup (TRAB, ultrasound, scan) can proceed concurrently 5, 2

Do Not Rely on TSH Alone for Monitoring

• TSH recovery lags behind normalization of thyroid hormones by weeks to months 5, 7
• Use free T4 and free T3 to guide dose adjustments in the first 3–6 months 7
• Persistent TSH suppression with normal free T4/T3 does not indicate inadequate treatment 5, 7

Do Not Measure T3 Routinely During Levothyroxine Therapy

• T3 measurement adds no value in assessing hypothyroid patients on levothyroxine replacement 4
• However, T3 is essential in diagnosing and monitoring hyperthyroidism, as 5% of cases present with isolated T3 toxicosis 3, 4

Recognize Severe Hyperthyroidism Requiring Higher Doses

• Patients with free T4 >2.5× upper limit of normal or symptomatic thyroid storm may require PTU 400–900 mg daily initially 6
• Consider hospitalization for severe cases with heart failure, atrial fibrillation, or altered mental status 6

---

Definitive Treatment Planning

After Achieving Euthyroid State (6–12 Months)

• Graves' disease: Consider radioactive iodine ablation or continued antithyroid drugs for 12–18 months 5, 2
• Toxic nodular goiter: Radioactive iodine or surgical resection is definitive therapy 5, 2
• Toxic adenoma: Radioactive iodine or surgical excision 5

Long-Term Monitoring

• Once on maintenance antithyroid therapy, check free T4, free T3, and TSH every 3–6 months 7
• After definitive treatment (radioablation/surgery), monitor for development of hypothyroidism requiring levothyroxine replacement 8, 7